Nu Skin Enterprises, Inc. (NUS) Stock Price & Analysis
Nu Skin Enterprises, Inc. (NUS) — MoonshotScore 49/100 (Fair band), calculated Oct 5, 2026. Price $4.61 (+1.32%), as of the Oct 2, 2026 trading session; market cap $224M.
Educational signal · not a buy or sell recommendation · How to read this
Nu Skin Enterprises, Inc. · NUS · NYSE
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products globally, focusing on skincare, nutritional supplements, and weight management. The company utilizes direct sales, distributors, and online channels to reach its customers.
Price as of Oct 2, 2026
Key Statistics
MoonshotScore v2 · Nu Skin Enterprises (NUS)
FairWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Cheap, but weak quality, a middling balance sheet and average growth, and the price trend has turned against it. Business Quality: Thin; Financial Safety: Okay; Valuation: Fair; Growth Durability: Flat; Momentum: Slipping.
- quarterly revenue $320M (Q2 FY2026, quarter ended Jun 2026)
- EPS beat 4 of 8
- Altman Z 3.70 · Piotroski F 4
Holding back: weak price trend
Helping: an attractive price
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 48 | Fair | |
| 48 | Fair | |
| 48 | Fair | |
| 48 | Fair | |
| 47 | Fair | |
| 47 | Fair |
The score moved from 48 in the stored Oct 4, 2026 snapshot to 49 in the current publication computed Oct 5, 2026 (+1); the largest pillar moves were Growth Durability +3. This current publication is not yet represented in the immutable snapshot archive.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $4.61 | |
| Change on the day | +1.32% | |
| 52-week range | $4.45 – $12.04 | |
| Market capitalisation | $224M | |
| Price / earnings (trailing) | 4.73 | |
| Shares traded on the day | 376.4K |
Price & events
Other perspectives
Council score for Nu Skin Enterprises (NUS): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
9-Factor Breakdown
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Oct 5, 2026, except a card that shows its own read date.
Watch the NUS film — every key number, told as a short cinematic story
~2 min · open the film
What is Nu Skin Enterprises (NUS), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Nu Skin Enterprises, Inc. (NUS) is listed on NYSE. It employs 2,800 people and is led by Ryan S. Napierski. In Q2 FY2026 it reported revenue of $320M and net income of -$250M. The market values it at $224M.
What do the latest results show for Nu Skin Enterprises (NUS)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $320M. Against analyst estimates the company has EPS beat 4 of 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $320M | -$250M | -$5.14 (diluted) |
| Q1 FY2026 | $321M | $2M | $0.04 (diluted) |
| Q4 FY2025 | $370M | $14M | $0.29 (diluted) |
| Q3 FY2025 | $364M | $17M | $0.34 (diluted) |
What are the financial strengths and risks for Nu Skin Enterprises (NUS)?
Short answer
The MoonshotScore pillars rate an attractive price as strengths. What is holding it back is weak price trend. The distress and quality screens read Altman Z 3.70 · Piotroski F 4. Trailing ratios: ROE -29.4% · ROA -19.3% · current ratio 1.98 · earnings yield -92.9% · free-cash-flow yield 4.6%.
How does Nu Skin Enterprises compare with its peers?
Short answer
Nu Skin Enterprises's score ranks 9th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
| Company | Price | Market value | Score |
|---|---|---|---|
| $113.95 Oct 2, 2026 | $3.65B | 94 5-pillar Oct 5, 2026 | |
| $75.75 Oct 5, 2026 | $1.76B | 92 5-pillar Oct 5, 2026 | |
| $63.50 Oct 2, 2026 | $242M | 79 5-pillar Oct 5, 2026 | |
| $7.13 Oct 2, 2026 | $32.8M | 77 5-pillar Oct 5, 2026 | |
| $105.44 Oct 5, 2026 | $6.21B | 72 5-pillar Oct 5, 2026 | |
| $6.17 Oct 2, 2026 | $42.1M | 60 5-pillar Oct 5, 2026 | |
| $26.75 Oct 5, 2026 | $1.23B | 50 5-pillar Oct 5, 2026 | |
| $82.01 Oct 5, 2026 | $9.92B | 50 5-pillar Oct 5, 2026 | |
| Nu Skin Enterprises (NUS) — this page | $4.61 | $224M | 49 |
| $26.68 Oct 5, 2026 | $621M | 43 5-pillar Oct 5, 2026 | |
| $6.64 Oct 2, 2026 | $12.8M | 39 5-pillar Oct 5, 2026 | |
| $0.60 Oct 5, 2026 | $77.8M | 25 5-pillar Oct 5, 2026 | |
| $5.48 Oct 5, 2026 | $2.33B | 25 5-pillar Oct 5, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Insider activity
Form 4 records via FMP · Available records within the last 180 days, newest dated Sep 9, 2026 (coverage not recorded)
- Transactions
- 3
- Identified insiders
- 2
- Purchases
- 0
- Sales
- 1
- Other transactions
- 2
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
What has been published about Nu Skin Enterprises (NUS)?
- Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
- Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26
- Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y
- Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript
Investor Questions: NUS Stock
These answers are editorial: 1 of these 9 answers is drawn from the NUS research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.
What does the MoonshotScore mean for NUS?
NUS carries the MoonshotScore stated above — the Fair band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.
Is NUS a good stock to buy?
Stock Expert AI does not rate NUS buy, sell or hold. Nu Skin Enterprises, Inc. carries a MoonshotScore, in the Fair band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the NUS stock price today?
The last price recorded on this page for Nu Skin Enterprises, Inc. (NUS) is $4.61, as of the Oct 2, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What do analysts say about NUS stock?
Analyst coverage of Nu Skin Enterprises, Inc. (NUS) is mixed, with some highlighting the company's potential for growth in emerging markets and its strong brand recognition.
What are the key factors to evaluate for NUS?
Nu Skin Enterprises, Inc. (NUS) holds a MoonshotScore in the low range. P/E: 4.73x. Strategic Partnerships and Acquisitions: Nu Skin can pursue strategic partnerships and acquisitions to expand its product portfolio, enter new markets, and gain access to new technologies. Not financial advice.
How frequently does NUS data refresh on this page?
NUS's price is the last quote we recorded, from the Oct 2, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven NUS's recent stock price performance?
Nu Skin Enterprises, Inc. (NUS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand recognition in the beauty and wellness industry. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NUS overvalued or undervalued right now?
Nu Skin Enterprises, Inc. (NUS) trades at 4.73x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of NUS?
Fractional-share availability for Nu Skin Enterprises, Inc. (NUS) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (18 figures)
The 18 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
FMP — 10 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $4.61 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T06:34:27.234Z. | |
px.change | Change on the day | +1.32% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalisation | $224M | FMP | Financial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:02.000Z. Captured from FMP at 2026-10-05T06:34:26.198Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
px.change_abs | Change on the day, in dollars | +$0.06 | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q2 FY2026 | $320M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
px.pe | Price / earnings (trailing) | 4.73 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 376.4K | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_income | Net income, Q2 FY2026 | -$250M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
own.insiders | Insider transactions via FMP | 3 transactions · 0 purchases, 1 sales, 2 other transactions · 2 identified insiders · available records within the last 180 days, newest dated Sep 9, 2026 (coverage not recorded) | FMP | Financial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent. |
UNRECORDED — 6 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.history | Reported versus estimated, recent quarters | EPS beat 4 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-09-17 · Expired observation | |
fin.scores | Distress and quality screens | Altman Z 3.70 · Piotroski F 4 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-04 · Expired observation | |
px.range52 | 52-week range | $4.45 – $12.04 | UNRECORDED | Stored company-profile observation — Captured 2026-10-01 | |
id.employees | Employees | 2,800 | UNRECORDED | Stored company-profile observation — Captured 2026-10-01 | |
id.ceo | Chief executive | Ryan S. Napierski | UNRECORDED | Stored company-profile observation — Captured 2026-10-01 | |
fin.ratios | Return and yield ratios (trailing twelve months) | ROE -29.4% · ROA -19.3% · current ratio 1.98 · earnings yield -92.9% · free-cash-flow yield 4.6% | — | UNRECORDED | Stored key metrics — Date unknown |
OURS — 2 facts from Stock Expert AI's own score and rank
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
ours.moonshot | MoonshotScore v2 | 49 of 100 · Fair · pillars 37 / 42 / 69 / 40 / 21 | OURS | Stock Expert AI MoonshotScore v2 engine | |
ours.moonshot_change | MoonshotScore movement | 48 (stored snapshot Oct 4, 2026) → 49 (current publication computed Oct 5, 2026) (+1) | OURS | Stock Expert AI current score publication and immutable score snapshots — The current score publication is not yet represented in the immutable snapshot archive. |
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Data provided for informational purposes only.
ETFs that hold NUS
Funds in our ETF coverage that list NUS among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
| ETF | Weight | Holdings as of |
|---|---|---|
| Validea Market Legends ETF (VALX) | 2.01% |